David Ricks, Eli Lilly CEO (Al Drago/Bloomberg via Getty Images)
May 1, 2025 02:33 PM EDT
Pharma
Manufacturing

Lil­ly CEO Ricks urges Trump to drop drug tar­iff plan

Drew Armstrong

Executive Editor

Eli Lil­ly CEO David Ricks con­tin­ued his push­back against the Trump ad­min­is­tra­tion’s plan to put tar­iffs on phar­ma­ceu­ti­cal prod­ucts made out­side the US, mak­ing some …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

RFK Jr. claims place­bo-con­trolled vac­cine tri­als are 'rad­i­cal de­par­ture' from past. Ex­perts dis­agree

US drug­mak­ers in­creas­ing­ly look abroad for clin­i­cal tri­als as con­fi­dence in FDA wa­vers

HHS launch­es $500M uni­ver­sal vac­cine plat­form as RFK Jr. shakes up US vac­cine pol­i­cy

Mod­er­na, fac­ing rev­enue miss­es and po­lit­i­cal head­winds, dis­ap­points Wall Street

CROs raise the alarm as clients de­lay R&D plans over fund­ing, tar­iff wor­ries

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times